ERYTECH reports financial highlights for Q1 2015 admERY May 5, 2015 Newsroom ERYTECH reports cash balance and revenues for the first quarter of 2015. You Might Also Like ERYTECH to raise approximately € 25.4 million in a private placement of ordinary shares to European and U.S. institutional investors December 3, 2015 ERYTECH wins Deloitte Technology Fast 50 “Promising Biotech Award” for France’s Grand Rhone-Alpes Region November 18, 2015 ERYTECH Announces Withdrawal of its European Marketing Authorization Application for GRASPA for Acute Lymphoblastic Leukemia and Prepares for Resubmission November 14, 2016
ERYTECH to raise approximately € 25.4 million in a private placement of ordinary shares to European and U.S. institutional investors December 3, 2015
ERYTECH wins Deloitte Technology Fast 50 “Promising Biotech Award” for France’s Grand Rhone-Alpes Region November 18, 2015
ERYTECH Announces Withdrawal of its European Marketing Authorization Application for GRASPA for Acute Lymphoblastic Leukemia and Prepares for Resubmission November 14, 2016
